Free Trial

Sana Biotechnology (SANA) SEC Filings & 10K Form

Sana Biotechnology logo
$2.92 +0.26 (+9.59%)
Closing price 03:59 PM Eastern
Extended Trading
$2.82 -0.10 (-3.43%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sana Biotechnology SEC Filings

DateFilerForm TypeView
03/10/2025
7:12 PM
Harr Steve (Reporting)
Sana Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:12 PM
Cassidy Bernard J (Reporting)
Sana Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:13 PM
Sana Biotechnology (Issuer)
Wyrick Susan D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:28 PM
Sana Biotechnology (Issuer)
Wyrick Susan D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
8:54 AM
Sana Biotechnology (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/16/2025
3:31 PM
Hordo Christian (Reporting)
Sana Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
8:00 AM
Sana Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
12:32 PM
FMR LLC (Reporting)
Sana Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:26 PM
Bishop Hans Edgar (Reporting)
Sana Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:33 PM
Hordo Christian (Reporting)
Sana Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
5:20 PM
Hardy Nathan (Reporting)
Sana Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:40 PM
Hardy Nathan (Reporting)
Sana Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
12:19 PM
FMR LLC (Reporting)
Sana Biotechnology (Issuer)
Form 3/A
11/14/2024
5:00 AM
CANADA PENSION PLAN INVESTMENT BOARD (Filed by)
Sana Biotechnology (Subject)
Form SC 13G/A
11/12/2024
3:52 PM
Sana Biotechnology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Sana Biotechnology (Subject)
Form SC 13G/A
11/08/2024
8:07 AM
Sana Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
8:14 AM
Sana Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
1:10 PM
Sana Biotechnology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Sana Biotechnology (Subject)
Form SC 13G
10/21/2024
4:19 PM
Hardy Nathan (Reporting)
Sana Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
5:43 PM
Sana Biotechnology (Issuer)
Wyrick Susan D. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2024
3:11 PM
Bishop Hans Edgar (Reporting)
Sana Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2024
3:07 PM
Mulligan Richard (Reporting)
Sana Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
3:28 PM
Mulligan Richard (Reporting)
Sana Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:36 PM
Sana Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
3:11 PM
Cole Douglas G. (Reporting)
Sana Biotechnology (Issuer)
Form 4/A
07/15/2024
3:11 PM
REICIN ALISE (Reporting)
Sana Biotechnology (Issuer)
Form 4/A
07/15/2024
3:12 PM
Sana Biotechnology (Issuer)
Seitz Michelle (Reporting)
Form 4/A
07/15/2024
3:12 PM
Sana Biotechnology (Issuer)
Wilderotter Mary Agnes (Reporting)
Form 4/A
07/15/2024
3:12 PM
NELSEN ROBERT (Reporting)
Sana Biotechnology (Issuer)
Form 4/A
07/15/2024
3:13 PM
Mulligan Richard (Reporting)
Sana Biotechnology (Issuer)
Form 4/A
07/15/2024
3:13 PM
Sana Biotechnology (Issuer)
Yang Patrick Y (Reporting)
Form 4/A
07/08/2024
3:32 PM
Bishop Hans Edgar (Reporting)
Sana Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:21 PM
Sana Biotechnology (Issuer)
Yang Patrick Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:49 PM
Sana Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/08/2024
3:21 PM
Sana Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
3:13 PM
Sana Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
5:15 AM
Sana Biotechnology (Filer)
Form ARS
04/26/2024
5:11 AM
Sana Biotechnology (Filer)
Form DEF 14A
04/26/2024
5:13 AM
Sana Biotechnology (Filer)
Form DEFA14A
Ex CIA predicts 40% “double crash” – April 11 (Ad)

The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… They’re studying something far more alien… Something you’ve never seen before…

Click here for my latest prediction before it’s taken offline.
04/18/2024
4:01 PM
Sana Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
3:51 PM
Bishop Hans Edgar (Reporting)
Sana Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
7:50 AM
FMR LLC (Reporting)
Sana Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
8:52 AM
FMR LLC (Filed by)
Sana Biotechnology (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:SANA) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners